DALIRESP®(roflumilast)is indicated as a treatment to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. Limitations of Use ...
Your Treatment Choices for Moderate-to-Severe COPD Medically Reviewed by Carol DerSarkissian, MD on April 27, 2023 Written by WebMD Editorial Contributors Medications Oxygen Therapy Surgery Pulmonary Rehabilitation 4 min read Even though there's no cure for chronic obstructive pulmonary disease (CO...
enhance their coping with COPD and improve their quality of life (QOL).This study aims to present the 'COPD-Home' as an integrated care model for patients with severe or very severe COPD.One principle of the COPD-Home model is that hospital treatment should lead to follow up in the patien...
117 patients were screened and 60 COPD patients entered a 1-month run-in period on low-dose ICS/LABA budesonide/formoterol (BUD/F) 200/6 one inhalation b.i.d. Patients were then randomly assigned to 3-month treatment with either a high dose BDP/F 100/6 two inhalations b.i.d. (n ...
This retrospective survey relied on the 12-month recall of patients for COPD-related hospitalizations, ED visits, primary care consultations, treatment and laboratory tests.23 Costs were derived by multiplying the unit cost of a resource by the frequency of the resource use in currency of the ...
Spanish COPD guidelines (GesEPOC) recommend considering whether cardiovascular disease is present when a patient's COPD is poorly controlled, despite receiving inhaled treatment and their primary clinical expression is dyspnea.34 Strategies to reduce cardiopulmonary risk and premature mortality should include...
Severity criteria for exacerbations of chronic obstructive pulmonary disease (COPD) have not yet been defined as they have for pneumonia. Therefore, investigators have usually adopted pragmatic criteria to define their study populations according to the subject of the study. For example, studies addressi...
However, this definition is not universally accepted, contributing to difficulties in developing treatment guidelines.1 Naming conventions for "long COVID" also vary and include post-acute SARS-CoV2 COVID (PASC), post-COVID syndrome, long COVID, and others.1,2 Further, the condition appears ...
Serum desmosine is higher in patients with AATD-COPD compared with usual COPD.43 Equally, administration of pooled human AAT has been shown to reduce serum levels of desmosine44 and has been suggested as a possible treatment for atherosclerosis in the context of myocardial in...
All patients in the No-Steroids group were admitted before June 16, 2020; after that date, the COVID-19 patients admitted to the ICU were treated with steroids (Steroids group) as a consequence of a change of treatment guidelines. The fact that steroids have been introduced at a specific ...